Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women
Carol J. Fabian(Washington Hospital), Stephen D. Hursting(National Cancer Institute), Sonya Aversman(University of Kansas), Jennifer R. Klemp(The University of Kansas Cancer Center), Bruce F. Kimler(The University of Kansas Cancer Center), Trina Metheny(University of Kansas), Joseph E. Donnelly(University of Kansas Medical Center), Teresa A. Phillips(University of Kansas), Hung‐Wen Yeh(Children's Mercy Hospital), Carola M. Zalles(Mercy Hospital), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Brian K. Petroff(University of Kansas), Debra K. Sullivan(University of Kansas)
Cited by 63
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
|Medicine & Science in Sports & Exercise|2009|2.6k
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
|Cancer Cell|2017|2.1k